LONG-TERM STABILITY OF PBCA NANOPARTICLE SUSPENSIONS SUGGESTS CLINICAL USEFULNESS

Citation
P. Sommerfeld et al., LONG-TERM STABILITY OF PBCA NANOPARTICLE SUSPENSIONS SUGGESTS CLINICAL USEFULNESS, International journal of pharmaceutics, 155(2), 1997, pp. 201-207
Citations number
19
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
03785173
Volume
155
Issue
2
Year of publication
1997
Pages
201 - 207
Database
ISI
SICI code
0378-5173(1997)155:2<201:LSOPNS>2.0.ZU;2-Z
Abstract
The stability of polybutylcyanoacrylate (PBCA) nanoparticle suspension s was examined by measuring particle sizes and size distributions over a period of 2 months in different solutions (hydrochloric acid, phosp hate buffered saline). When stored in acidic medium, nanoparticles wer e found ro be stable for at least 2 months. In this case, degradation of the polymer is decelerated and particle agglomeration is reduced. W hen added to human blood serum, nanoparticles were found not to agglom erate, remaining stable in size for al least five days. Previous stabi lization protocols required lyophilization and resuspension by ultraso nification; however, the technique presented here using acidic storage solutions proves to be superior for clinical applications. (C) 1997 E lsevier Science B.V.